An open-label, single-sequence crossover study of DS-8500a to evaluate the effects on the pharmacokinetics of atorvastatin in Japanese healthy subjects
Latest Information Update: 23 Jul 2019
At a glance
- Drugs Firuglipel (Primary) ; Atorvastatin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 18 Jul 2019 Results assessing the effects of repeated oral administration of DS-8500a 75 mg on the pharmacokinetics of rosuvastatin and atorvastatin in healthy adults, published in the Clinical Drug Investigation
- 16 Jun 2016 New trial record